132 related articles for article (PubMed ID: 9187180)
1. Recombinant interferon alpha-2b in the management of malignant pleural effusions.
Wilkins HE; Connolly MM; Grays P; Marquez G; Nelson D
Chest; 1997 Jun; 111(6):1597-9. PubMed ID: 9187180
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
Sartori S; Tassinari D; Ceccotti P; Tombesi P; Nielsen I; Trevisani L; Abbasciano V
J Clin Oncol; 2004 Apr; 22(7):1228-33. PubMed ID: 15051770
[TBL] [Abstract][Full Text] [Related]
3. Interferon instillation for malignant pleural effusions.
Goldman CA; Skinnider LF; Maksymiuk AW
Ann Oncol; 1993 Feb; 4(2):141-5. PubMed ID: 8448082
[TBL] [Abstract][Full Text] [Related]
4. A phase I-II study of recombinant intrapleural alpha interferon in malignant pleural effusions.
Davis M; Williford S; Muss HB; White DR; Cooper MR; Jackson DV; Barrett R
Am J Clin Oncol; 1992 Aug; 15(4):328-30. PubMed ID: 1514530
[TBL] [Abstract][Full Text] [Related]
5. Intrapericardial interferon in the management of malignant pericardial effusion.
Wilkins HE; Cacioppo J; Connolly MM; Marquez G; Grays P
Chest; 1998 Jul; 114(1):330-1. PubMed ID: 9674491
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of intrapleural recombinant human interferon alpha (rHuIFN alpha 2b) in patients with malignant pleural effusions.
Bhatia A; Rice TW; McLain D; Herzog P; Budd GT; Murthy S; Kirby TJ; Bukowski RM
J Cancer Res Clin Oncol; 1994; 120(3):169-72. PubMed ID: 8263014
[TBL] [Abstract][Full Text] [Related]
7. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural hyperthermic perfusion using distilled water at 48 °C for malignant pleural effusion.
Ba M; Long H; Wang Y; Tang Y; Wu Y; Zhang X; Cui S
J Cancer Res Clin Oncol; 2013 Dec; 139(12):2005-12. PubMed ID: 24072234
[TBL] [Abstract][Full Text] [Related]
9. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions.
Crnjac A
Wien Klin Wochenschr; 2004; 116 Suppl 2():28-32. PubMed ID: 15506307
[TBL] [Abstract][Full Text] [Related]
10. Intracavitary bleomycin vs interferon in the management of malignant pleural effusions.
Sartori S; Trevisani L; Nielsen I; Tassinari D; Abbasciano V
Chest; 1998 Apr; 113(4):1145-6. PubMed ID: 9554669
[No Abstract] [Full Text] [Related]
11. Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation.
Bukowski RM; Tendler C; Cutler D; Rose E; Laughlin MM; Statkevich P
Cancer; 2002 Jul; 95(2):389-96. PubMed ID: 12124839
[TBL] [Abstract][Full Text] [Related]
12. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
13. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters.
Suzuki K; Servais EL; Rizk NP; Solomon SB; Sima CS; Park BJ; Kachala SS; Zlobinsky M; Rusch VW; Adusumilli PS
J Thorac Oncol; 2011 Apr; 6(4):762-7. PubMed ID: 21325982
[TBL] [Abstract][Full Text] [Related]
14. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions.
Parulekar W; Di Primio G; Matzinger F; Dennie C; Bociek G
Chest; 2001 Jul; 120(1):19-25. PubMed ID: 11451810
[TBL] [Abstract][Full Text] [Related]
15. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
[TBL] [Abstract][Full Text] [Related]
16. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
Kang MQ; Cao YP; Deng F
Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
[TBL] [Abstract][Full Text] [Related]
17. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis.
Marom EM; Patz EF; Erasmus JJ; McAdams HP; Goodman PC; Herndon JE
Radiology; 1999 Jan; 210(1):277-81. PubMed ID: 9885620
[TBL] [Abstract][Full Text] [Related]
18. The palliative treatment with intrapleural streptokinase in patients with multiloculated malignant pleural effusion: a double-blind, placebo-controlled, randomized study.
Saydam O; Karapinar K; Gokce M; Kilic L; Metin M; Oz II; Tanriverdi O
Med Oncol; 2015 Jun; 32(6):612. PubMed ID: 25958101
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of malignant pleural effusions.
Murthy SC; Rice TW
Thorac Surg Clin; 2013 Feb; 23(1):43-9, vi. PubMed ID: 23206716
[TBL] [Abstract][Full Text] [Related]
20. [Interferon therapy of the lung and locoregional therapy in pulmology].
Pohl WR
Wien Med Wochenschr; 1993; 143(16-17):450-4. PubMed ID: 7505989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
